0001732524-18-000001.txt : 20180223 0001732524-18-000001.hdr.sgml : 20180223 20180223084527 ACCESSION NUMBER: 0001732524-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180223 DATE AS OF CHANGE: 20180223 EFFECTIVENESS DATE: 20180223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Panther Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001732524 IRS NUMBER: 823072987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-306279 FILM NUMBER: 18634732 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 301-204-6781 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001732524 Panther Pharmaceuticals, Inc. ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA MASSACHUSETTS 02139 301-204-6781 DELAWARE None None Corporation true 2017 Per Lindell One Kendall Square Building 200 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Michael Tolentino One Kendall Square Building 200 Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2018-02-08 false true false 5000 500000 200000 300000 false 2 0 0 0 false Panther Pharmaceuticals, Inc. Per Lindell Per Lindell CEO 2018-02-23